Entity
Description
  • Value proposition

    Combining human and machine intelligence to discover the next generation of therapeutic antibodies.

    LabGenius Therapeutics ("LabGenius") is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company’s discovery platform, EVATM, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation and synthetic biology. While EVATM is both modality and format-agnostic, LabGenius' internal pipeline is focussed on the development of selectivity-enhanced antibodies for the treatment of solid tumours. The company's novel approach is delivering a pipeline of antibody therapeutics with best-in-class killing profiles.

    Medical, Health, and DNA Libraries

  • LabGenius Therapeutics | ML-driven Antibody Discovery

    Combining human and machine intelligence to discover the next generation of therapeutic antibodies.

  • https://labgeniustx.com/
Catalyst interactions
Catalyst TypeTweets Articles
Moderna
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Other

30 May 2024


Gilead Sciences
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research
Other

30 Apr 2024


NYSE
NYSE
Finance, Financial Services
NYSE
Finance, Financial Services
Other

30 Apr 2024


Apple
Apple
Consumer Electronics, Computers and Electronics Manufacturing
Apple
Consumer Electronics, Computers and Electronics Manufacturing
Other

21 Jan 2024


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

30 May 2024


techUK
techUK
National and local authorities, IT Services and IT Consulting
techUK
National and local authorities, IT Services and IT Consulting
Other

15 Sep 2021


UK Atomic Energy Authority
UK Atomic Energy Authority
Research, National and local authorities
UK Atomic Energy Authority
Research, National and local authorities
Other

31 Dec 2023


CB Insights
CB Insights
Consulting, Technology, Information and Internet
CB Insights
Consulting, Technology, Information and Internet
Capitalistic
Partnership
Event

24 Dec 2019


Entrepreneur First
Entrepreneur First
Startup accelerator & VC, Venture Capital and Private Equity Principals
Entrepreneur First
Startup accelerator & VC, Venture Capital and Private Equity Principals
Not capitalistic
Not partnership
Event

10 Mar 2020


IBM
IBM
IT services, IT Services and IT Consulting
IBM
IT services, IT Services and IT Consulting
Not capitalistic
Not partnership
Event

30 Apr 2019


Social network dynamics
Similar entities
BETA
Loading...
Loading...